COLL Collegium Pharmaceutical, Inc.
$23.00▼ -0.90%
Healthcare
Other
After hours
$23.00▲ +0.00%
Oct 27, 4:01 PM ET
Volume 486.6K
Avg Volume (10D) 697.7K
Key Metrics & Fundamentals
Market Cap
$748.78M
P/E Ratio
18.1
Div Yield
0.00%
52W Range
21.43 - 50.79
% vs 50 MA
-2.43%
% vs 200 MA
-31.53%
RSI-14
49.4
MACD Histogram
+0.2200
Beta (1Y vs SPY)
0.29
Free Cash Flow
$70.83M
Gross Rev
$199.88M
Gross Profit
$110.29M
EBITDA
$70.75M
COGS
$89.59M
Operating Exp
$106.59M
Operating Income
$3.70M
EBIT
$3.70M
Pretax Income
-$13.53M
Net Income
-$15.05M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
Zacks · Oct 27, 2026 11:16 AM ET
Q2 earnings highs and lows: Collegium Pharmaceutical (NASDAQ:COLL) vs the rest of the branded pharmaceuticals stocks
StockStory · Oct 26, 2026 7:42 PM ET
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
GlobeNewswire · Oct 22, 2026 8:00 AM ET
Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses
GlobeNewswire · Oct 21, 2026 8:00 AM ET
Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million
MT Newswires · Oct 19, 2026 5:52 PM ET
COLL vs. DSNKY: Which Stock Is the Better Value Option?
Zacks · Oct 19, 2026 10:40 AM ET
Does Collegium Pharmaceutical (COLL) Have the Potential to Rally 111.39% as Wall Street Analysts Expect?
Zacks · Oct 16, 2026 8:55 AM ET
Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says
MT Newswires · Oct 9, 2026 1:32 PM ET
New Strong Sell Stocks for October 7th
Zacks · Oct 7, 2026 2:23 AM ET
Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
GlobeNewswire · Oct 6, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See COLL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.